NCT04739267View on ClinicalTrials.gov

Acute Coronary Syndrome CardioFlux TM Study (ACCMED)

CompletedOBSERVATIONAL
Enrollment

390

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

March 3, 2023

Conditions
Acute Myocardial Injuries
Interventions
DEVICE

CardioFlux

Not an intervention

Trial Locations (1)

45040

Genetesis Facility, Mason

Sponsors

Lead Sponsor

Genetesis Inc.
All Listed Sponsors
lead

Genetesis Inc.

INDUSTRY

NCT04739267 - Acute Coronary Syndrome CardioFlux TM Study (ACCMED) | Biotech Hunter | Biotech Hunter